ARS Pharmaceuticals, Inc. (SPRY)
NASDAQ: SPRY · Real-Time Price · USD
17.87
+0.31 (1.77%)
At close: Jul 16, 2025, 4:00 PM
17.51
-0.36 (-2.01%)
After-hours: Jul 16, 2025, 7:34 PM EDT

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2023FY 2022
Period Ending
Dec '23 Dec '22
Needle-free Intranasal
30.00K
Log In
Needle-free Intranasal Growth
-97.72%
Log In

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2023FY 2022
Period Ending
Dec '23 Dec '22
United States
30.00K
Log In
United States Growth
-97.72%
Log In